- Home
- UAMY vs ABP Comparison
UAMY vs ABP Comparison
Compare UAMY & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UAMY
- ABP
- Stock Information
- Founded
- UAMY 1968
- ABP 2004
- Country
- UAMY United States
- ABP United States
- Employees
- UAMY N/A
- ABP N/A
- Industry
- UAMY Metal Fabrications
- ABP Biotechnology: Pharmaceutical Preparations
- Sector
- UAMY Industrials
- ABP Health Care
- Exchange
- UAMY Nasdaq
- ABP Nasdaq
- Market Cap
- UAMY 74.2M
- ABP 78.8M
- IPO Year
- UAMY N/A
- ABP N/A
- Fundamental
- Price
- UAMY $1.93
- ABP $1.24
- Analyst Decision
- UAMY Strong Buy
- ABP
- Analyst Count
- UAMY 2
- ABP 0
- Target Price
- UAMY $1.75
- ABP N/A
- AVG Volume (30 Days)
- UAMY 7.2M
- ABP 47.2K
- Earning Date
- UAMY 11-12-2024
- ABP 04-03-2025
- Dividend Yield
- UAMY N/A
- ABP N/A
- EPS Growth
- UAMY N/A
- ABP N/A
- EPS
- UAMY N/A
- ABP N/A
- Revenue
- UAMY $10,219,826.00
- ABP $122,000.00
- Revenue This Year
- UAMY N/A
- ABP N/A
- Revenue Next Year
- UAMY N/A
- ABP N/A
- P/E Ratio
- UAMY N/A
- ABP N/A
- Revenue Growth
- UAMY 28.40
- ABP N/A
- 52 Week Low
- UAMY $0.17
- ABP $1.19
- 52 Week High
- UAMY $2.35
- ABP $13.00
- Technical
- Relative Strength Index (RSI)
- UAMY 74.22
- ABP N/A
- Support Level
- UAMY $1.90
- ABP N/A
- Resistance Level
- UAMY $2.35
- ABP N/A
- Average True Range (ATR)
- UAMY 0.32
- ABP 0.00
- MACD
- UAMY 0.09
- ABP 0.00
- Stochastic Oscillator
- UAMY 83.60
- ABP 0.00
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.
About ABP Abpro Holdings Inc Common Stock
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.